pI: 8.4231 |
Length (AA): 1529 |
MW (Da): 174085 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1299 | 1506 | 1z5z (A) | 704 | 890 | 31.00 | 0.00000013 | 1 | 0.34 | -0.25 |
1317 | 1503 | 1fuk (A) | 235 | 394 | 15.00 | 0.00002 | 0.19 | 0.11 | -0.33 |
26 | 246 | 4tql (A) | 9 | 231 | 9.00 | 0.00000028 | 0 | 0.190939 | -0.16 |
1226 | 1276 | 5din (A) | 21 | 58 | 45.00 | 0.29 | 0.4 | -0.0111449 | 1.85 |
1247 | 1316 | 4s3o (C) | 16 | 82 | 30.00 | 0.053 | 0.95 | 0.341282 | 0 |
1247 | 1291 | 2djb (A) | 16 | 57 | 45.00 | 0.13 | 0.67 | 0.180931 | 1.26 |
1299 | 1506 | 1z5z (A) | 704 | 890 | 31.00 | 0.000001 | 1 | 0.306537 | 0.1 |
1409 | 1482 | 3dmq (A) | 551 | 623 | 37.00 | 0.0022 | 0.48 | 0.278898 | 1.68 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 36 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_127144)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G02670 | P-loop containing nucleoside triphosphate hydrolases superfamily protein |
Arabidopsis thaliana | AT5G43530 | Helicase protein with RING/U-box domain |
Arabidopsis thaliana | AT5G05130 | DNA/RNA helicase |
Arabidopsis thaliana | AT5G22750 | DNA/RNA helicase protein RAD5 |
Brugia malayi | Bm1_31435 | SNF2 family N-terminal domain containing protein |
Candida albicans | CaO19.2097 | similar to putative RAD5 ATPase/DNA helicase (SNF2 family helicase domain) |
Candida albicans | CaO19.9644 | similar to putative RAD5 ATPase/DNA helicase (SNF2 family helicase domain) |
Caenorhabditis elegans | CELE_T23H2.3 | Protein T23H2.3 |
Caenorhabditis elegans | CELE_F54E12.2 | Protein F54E12.2 |
Dictyostelium discoideum | DDB_G0272082 | C3HC4-type zinc finger-containing protein |
Dictyostelium discoideum | DDB_G0282115 | C3HC4-type zinc finger-containing protein |
Dictyostelium discoideum | DDB_G0281949 | CHR group protein |
Drosophila melanogaster | Dmel_CG10445 | CG10445 gene product from transcript CG10445-RD |
Drosophila melanogaster | Dmel_CG2684 | lodestar |
Echinococcus granulosus | EgrG_000412300 | Zinc finger RING type |
Homo sapiens | 8458 | transcription termination factor, RNA polymerase II |
Homo sapiens | ENSG00000071794 | helicase-like transcription factor |
Leishmania braziliensis | LbrM.28.2000 | DNA repair protein-like protein |
Leishmania braziliensis | LbrM.28.0790 | DNA repair protein, putative |
Leishmania donovani | LdBPK_281950.1 | DNA repair protein-like protein |
Leishmania donovani | LdBPK_280810.1 | DNA repair protein, putative |
Leishmania infantum | LinJ.28.0810 | DNA repair protein, putative |
Leishmania infantum | LinJ.28.1950 | DNA repair protein-like protein |
Leishmania major | LmjF.28.1830 | DNA repair protein-like protein |
Leishmania major | LmjF.28.0760 | DNA repair protein, putative |
Leishmania mexicana | LmxM.28.1830 | DNA repair protein-like protein |
Leishmania mexicana | LmxM.28.0760 | DNA repair protein, putative |
Loa Loa (eye worm) | LOAG_04901 | hypothetical protein |
Loa Loa (eye worm) | LOAG_04903 | hypothetical protein |
Loa Loa (eye worm) | LOAG_04902 | hypothetical protein |
Mus musculus | ENSMUSG00000002428 | helicase-like transcription factor |
Mus musculus | ENSMUSG00000033222 | transcription termination factor, RNA polymerase II |
Neospora caninum | NCLIV_011070 | AAR147Wp, related |
Oryza sativa | 4329524 | Os02g0527100 |
Oryza sativa | 4344076 | Os07g0642400 |
Oryza sativa | 4335086 | Os04g0177300 |
Onchocerca volvulus | OVOC2773 | Transcription termination factor 2 homolog |
Plasmodium berghei | PBANKA_1356400 | DNA repair protein RAD5, putative |
Plasmodium falciparum | PF3D7_1343400 | DNA repair protein RAD5, putative |
Plasmodium knowlesi | PKNH_1258000 | DNA repair protein RAD5, putative |
Plasmodium vivax | PVX_083065 | DNA repair protein RAD5, putative |
Plasmodium yoelii | PY02949 | DNA repair protein-like-related |
Saccharomyces cerevisiae | YLR032W | DNA helicase RAD5 |
Trypanosoma brucei gambiense | Tbg972.11.9160 | DNA repair protein, putative |
Trypanosoma brucei | Tb927.11.8010 | DNA repair protein, putative |
Trypanosoma congolense | TcIL3000_0_20470 | DNA repair protein, putative |
Trypanosoma congolense | TcIL3000.11.8530 | DNA repair protein, putative |
Trypanosoma cruzi | TcCLB.504041.29 | DNA repair protein, putative |
Trypanosoma cruzi | TcCLB.508815.30 | DNA repair protein, putative |
Toxoplasma gondii | TGME49_318480 | SWI2/SNF2-containing protein RAD5 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0530 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0530 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0530 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0530 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F54E12.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1356400 | Plasmodium berghei | Dispensable | plasmo |
TGME49_318480 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.